| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Transmembrane protease serine 2 |
|---|
| Ligand | BDBM50606672 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_2261069 (CHEMBL5216080) |
|---|
| Ki | 3.0±n/a nM |
|---|
| Citation |  Paulsson-Habegger, L; Snabaitis, AK; Wren, SP Enzyme inhibition as a potential therapeutic strategy to treat COVID-19 infection. Bioorg Med Chem48:0 (2021) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Transmembrane protease serine 2 |
|---|
| Name: | Transmembrane protease serine 2 |
|---|
| Synonyms: | PRSS10 | Serine protease 10 | TMPRSS2 | TMPS2_HUMAN | Transmembrane protease serine 2 catalytic chain | Transmembrane protease serine 2 non-catalytic chain |
|---|
| Type: | PROTEIN |
|---|
| Mol. Mass.: | 53867.70 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | ChEMBL_760112 |
|---|
| Residue: | 492 |
|---|
| Sequence: | MALNSGSPPAIGPYYENHGYQPENPYPAQPTVVPTVYEVHPAQYYPSPVPQYAPRVLTQA
SNPVVCTQPKSPSGTVCTSKTKKALCITLTLGTFLVGAALAAGLLWKFMGSKCSNSGIEC
DSSGTCINPSNWCDGVSHCPGGEDENRCVRLYGPNFILQVYSSQRKSWHPVCQDDWNENY
GRAACRDMGYKNNFYSSQGIVDDSGSTSFMKLNTSAGNVDIYKKLYHSDACSSKAVVSLR
CIACGVNLNSSRQSRIVGGESALPGAWPWQVSLHVQNVHVCGGSIITPEWIVTAAHCVEK
PLNNPWHWTAFAGILRQSFMFYGAGYQVEKVISHPNYDSKTKNNDIALMKLQKPLTFNDL
VKPVCLPNPGMMLQPEQLCWISGWGATEEKGKTSEVLNAAKVLLIETQRCNSRYVYDNLI
TPAMICAGFLQGNVDSCQGDSGGPLVTSKNNIWWLIGDTSWGSGCAKAYRPGVYGNVMVF
TDWIYRQMRADG
|
|
|
|---|
| BDBM50606672 |
|---|
| n/a |
|---|
| Name | BDBM50606672 |
|---|
| Synonyms: | CHEMBL3219101 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C31H36Cl2N6O4S |
|---|
| Mol. Mass. | 659.626 |
|---|
| SMILES | CNC(=O)NCCC1CCN(CC1)C(=O)[C@H](Cc1cccc(c1)C(N)=N)NS(=O)(=O)c1cccc(c1)-c1ccc(Cl)cc1Cl |r| |
|---|
| Structure | 
|
|---|
Search and Browse
